Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.
JAK-STAT Pathway: A Novel Target to Tackle Viral Infections.
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
Autoimmune B Cell Repertoire in a Mouse Model of Sjögren's Syndrome.
Predictors of attrition among adults in a rural HIV clinic in southern Mozambique: 18-year retrospective study.
Self-collected mid-nasal swabs and saliva specimens, compared with nasopharyngeal swabs, for SARS-CoV-2 detection in mild COVID-19 patients.
Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles
Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection.
Erratum for Puertas et al., "VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies".
A Cost-Benefit Analysis of COVID-19 Vaccination in Catalonia.